PTC Therapeutics
PTCT
$32.14
Share price
12.50%
Change (1 day)
-41.71%
Change (1 year)
Categories
PTC Therapeutics (PTCT) - Cash on Hand
Cash on Hand as of December 2023 : $0.87 B
According to PTC Therapeutics
's latest financial reports the company has $0.87 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
PTC Therapeutics - Cash on Hand chart (from 2012 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.87 B | 113.47% |
| 2022-12-31 | $0.41 B | -46.89% |
| 2021-12-31 | $0.77 B | -29.93% |
| 2020-12-31 | $1.10 B | 60.75% |
| 2019-12-31 | $0.68 B | 201.67% |
| 2018-12-31 | $0.22 B | 19% |
| 2017-12-31 | $0.19 B | -17.45% |
| 2016-12-31 | $0.23 B | -31.65% |
| 2015-12-31 | $0.33 B | 7.51% |
| 2014-12-31 | $0.31 B | 121.27% |
| 2013-12-31 | $0.14 B | 5126.8% |
| 2012-12-31 | $2.72 M | -90.41% |
| 2011-12-31 | $28.43 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $9.69 B | 1,005.69% | 🇨🇭 Switzerland |
 Vertex Pharmaceuticals VRTX | $11.21 B | 1,179.55% | 🇺🇸 USA |
 Xencor XNCR | $0.59 B | -32.28% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | $1.67 B | 91.19% | 🇺🇸 USA |
 Fate Therapeutics
FATE | $0.31 B | -64.05% | 🇺🇸 USA |
 Avidity Biosciences RNA | $0.59 B | -32.09% | 🇺🇸 USA |